Magnetic resonance spectroscopy imaging‐directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate‐specific antigen between 4–10 ng/mL and normal digital rectal examination

To evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate.

[1]  N. Ben Rais,et al.  The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[2]  H. Hricak,et al.  Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. , 2012, Radiology.

[3]  N. Jagannathan,et al.  Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.

[4]  A. Dinda,et al.  A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer , 2012, Indian journal of urology : IJU : journal of the Urological Society of India.

[5]  Thomas Hambrock,et al.  In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.

[6]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[7]  B. Barbiroli,et al.  Accuracy of MRI/MRSI‐based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy , 2010, NMR in biomedicine.

[8]  Adilson Prando,et al.  Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging , 2010 .

[9]  H. Honda,et al.  Prostate cancer detection: the value of performing an MRI before a biopsy , 2009, Acta radiologica.

[10]  Peter H Gann,et al.  Prostate specific antigen best practice statement: 2009 update. , 2009, The Journal of urology.

[11]  A. Hemal,et al.  Potential of 1H MR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy , 2009, Journal of magnetic resonance imaging : JMRI.

[12]  Caroline Moore,et al.  Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. , 2009, Surgical oncology.

[13]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[14]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[15]  Rajeev Kumar,et al.  Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. , 2008, Urology.

[16]  N. Jagannathan,et al.  Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[17]  Donald E Bailey,et al.  Active surveillance for early‐stage prostate cancer , 2008, Cancer.

[18]  Peter Guion,et al.  Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.

[19]  M. Schell,et al.  A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions , 2008, Cancer.

[20]  Rodolfo Montironi,et al.  Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.

[21]  M. Desai,et al.  Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population , 2007, Indian journal of urology : IJU : journal of the Urological Society of India.

[22]  A. Hemal,et al.  Transrectal ultrasound‐guided biopsy of prostate voxels identified as suspicious of malignancy on three‐dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/ml , 2007, NMR in biomedicine.

[23]  B. Daniel,et al.  Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study. , 2004, Medical physics.

[24]  P. Carroll,et al.  Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.

[25]  E. Crawford,et al.  Screening for prostate cancer: current recommendations. , 2004, The Urologic clinics of North America.

[26]  P. Carroll,et al.  Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.

[27]  A. Weaver,et al.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. , 2001, The Journal of urology.

[28]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[29]  Michael Garwood,et al.  Solvent Suppression Using Selective Echo Dephasing , 1996 .

[30]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[31]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[32]  A. Villers,et al.  Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology , 2009, The Prostate.

[33]  Aastha Gupta,et al.  Measurement of serum PSA in benign and malignant enlargements of prostate in Indian population: Relevance of PSAD in intermediate range PSA , 2004, Indian Journal of Urology.

[34]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[35]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[36]  M. Terris,et al.  Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. , 1997, Urologia internationalis.